We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+18.1%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.52B
AUM Growth
+$95.3M
Cap. Flow
-$53M
Cap. Flow %
-3.48%
Top 10 Hldgs %
46.4%
Holding
811
New
169
Increased
201
Reduced
172
Closed
223

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$66.9M
2
SAGE
Sage Therapeutics
SAGE
+$26.6M
3
IMO icon
Imperial Oil
IMO
+$24.9M
4
COIN icon
Coinbase
COIN
+$22.5M
5
ANSCU
Agriculture & Natural Solutions Acquisition Corp Unit
ANSCU
+$21.6M

Top Sells

Rank Stock Value
1
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$48.7M
2
AAC
Ares Acquisition Corporation
AAC
+$36.4M
3
PTGX icon
Protagonist Therapeutics
PTGX
+$27.6M
4
HCVIU
Hennessy Capital Investment Corp. VI Unit
HCVIU
+$17.4M
5
NETD
Nabors Energy Transition Corp II
NETD
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 30.8%
2 Financials 24.54%
3 Technology 21.73%
4 Communication Services 4.41%
5 Energy 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLBR.U
51
DELISTED
Colombier Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CLBR.U
$4.95M 0.32%
+490,829
New +$4.94M
AFJKU
52
Aimei Health Technology Co Unit
AFJKU
$72M
$4.86M 0.32%
+476,428
New +$4.84M
HTZWW
53
Hertz Global Holdings Warrants
HTZWW
$89.4M
$4.85M 0.32%
+885,855
New +$4.48M
CYTK icon
54
Cytokinetics
CYTK
$10.5B
$4.74M 0.31%
+56,828
New +$2.06M
ZLS
55
DELISTED
Zalatoris II Acquisition Corp Class A Ordinary Shares
ZLS
$4.68M 0.31%
437,578
+182,049
+71% +$1.94M
GAQ
56
DELISTED
Generation Asia I Acquisition Limited Class A Ordinary Shares
GAQ
$4.61M 0.3%
+424,458
New +$4.59M
LCW
57
DELISTED
Learn CW Investment Corporation Class A Ordinary Shares
LCW
$4.58M 0.3%
422,509
+126,592
+43% +$1.36M
SKGR
58
DELISTED
SK Growth Opportunities Corporation Class A Common Stock
SKGR
$4.18M 0.27%
386,395
-708,828
-65% -$7.66M
GODN
59
DELISTED
Golden Star Acquisition Corporation Ordinary Shares
GODN
$4.13M 0.27%
396,636
-54,904
-12% -$570K
TBMC
60
DELISTED
Trailblazer Merger Corp I
TBMC
$4.12M 0.27%
394,234
+205,380
+109% +$2.13M
FTII
61
DELISTED
FutureTech II Acquisition Corp. Class A Common Stock
FTII
$4.1M 0.27%
+377,119
New +$4.11M
MARX
62
DELISTED
Mars Acquisition Corp. Ordinary Shares
MARX
$4.08M 0.27%
384,067
+35,734
+10% +$378K
IROHU
63
DELISTED
Iron Horse Acquisitions Corp Unit
IROHU
$4.02M 0.26%
+400,000
New +$4.01M
THCP
64
DELISTED
Thunder Bridge Capital Partners IV, Inc. Class A Common Stock
THCP
$4.01M 0.26%
392,694
+142,494
+57% +$1.46M
APLS
65
DELISTED
Apellis Pharmaceuticals
APLS
$3.98M 0.26%
+66,470
New +$3.37M
KRNL
66
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
$3.95M 0.26%
367,822
+35,304
+11% +$376K
IMGN
67
DELISTED
Immunogen Inc
IMGN
$3.89M 0.26%
+131,099
New +$2.61M
USCT
68
DELISTED
Roth CH Acquisition Co. Class A Ordinary Shares
USCT
$3.86M 0.25%
352,692
+287,692
+443% +$3.14M
CNTM
69
DELISTED
ConnectM Technology Solutions, Inc. Common Stock
CNTM
$3.83M 0.25%
352,730
+337,883
+2,276% +$3.64M
DSAQ
70
DELISTED
Direct Selling Acquisition Corp.
DSAQ
$3.81M 0.25%
350,000
-97,351
-22% -$1.06M
ALB icon
71
Albemarle
ALB
$15.5B
$3.73M 0.24%
+25,837
New +$3.55M
AITRU
72
DELISTED
AI Transportation Acquisition Corp Unit
AITRU
$3.73M 0.24%
+365,226
New +$3.72M
GLST
73
DELISTED
Global Star Acquisition, Inc. Class A Common Stock
GLST
$3.67M 0.24%
345,882
+258,500
+296% +$2.75M
BPMC
74
DELISTED
Blueprint Medicines
BPMC
$3.54M 0.23%
+38,353
New +$2.49M
GOOGL icon
75
Alphabet (Google) Class A
GOOGL
$4.37T
$3.49M 0.23%
25,001
+1
+0% +$134
1 2
3
4 5

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q4 2023 Portfolio in Review

As of Q4 2023, Cowen and Company held 811 positions worth $1.52B, up 6.7% from $1.43B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cowen and Company withdrew a net $53M in Q4 2023, closing 223 positions and reducing 172 holdings. Its most notable exit was AdvisorShares Pure US Cannabis ETF, an estimated $48.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 22% a quarter earlier, followed by Financials and Technology.

Against the trend, Cowen and Company opened a new position in Sage Therapeutics worth $29M.

  • Cowen and Company's largest Q4 2023 buy was Sage Therapeutics: 1,339,971 shares worth $29M.
  • Cowen and Company added most to PTC Therapeutics in Q4 2023, an estimated $66.9M increase.
  • Cowen and Company's biggest Q4 2023 reduction was Nabors Energy Transition Corp II, cutting an estimated $16.9M.
  • Cowen and Company fully exited AdvisorShares Pure US Cannabis ETF in Q4 2023, selling an estimated $48.7M.
  • Cowen and Company's ten largest holdings make up 46% of its $1.52B portfolio in Q4 2023.
  • Cowen and Company opened 169 new positions and closed 223 in Q4 2023.
  • Cowen and Company's portfolio value rose 6.7% quarter-over-quarter to $1.52B.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.